Preferential Issue, QIP or IPO: Understanding Fundraising Routes

A board that decides to "raise equity" has not yet made a decision. The company may be unlisted or listed, may want a broad shareholder base or one or two anchor investors, and may need money in a few weeks or can plan for a year. Those facts, more than any preference for a particular label, decide which route is even available.

The short answer. An Initial Public Offer (IPO) is the route for a company that is not yet listed and wants to sell shares to the public and list them. A Qualified Institutions Placement (QIP) and a preferential issue are available only to companies that are already listed, and neither is a substitute for an IPO. A QIP raises money from institutional investors; a preferential issue allots shares to selected investors, often a strategic partner or the promoters themselves. A rights issue, offered to existing shareholders, is a fourth option for listed companies. The rules below are taken from the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 ("ICDR Regulations"), as amended up to March 2026, and must be re-checked before any transaction.

1. Overview of Corporate Fundraising Options

The table sets out the main equity routes side by side.

Companies also use bank debt, non-convertible debentures, private equity or venture investment, and pre-IPO private placements. These are financing choices rather than public equity routes, and each has its own rules.

2. Initial Public Offer

An IPO is an offer of specified securities by an unlisted issuer to the public for subscription, and it can include an offer for sale by existing holders. It is the only route in this comparison that creates a listed company, which brings a wider shareholder base, a market price and continuing disclosure obligations.

Main Board. Regulation 6(1) of the ICDR Regulations sets the standard track record test: net tangible assets of at least ₹3 crore in each of the preceding three full years (with a limit on monetary assets), an average operating profit of at least ₹15 crore over the preceding three years with operating profit in each of those years, and net worth of at least ₹1 crore in each of the three years, all on a restated and consolidated basis. An issuer that does not meet this test may still proceed under Regulation 6(2), but only through book building with at least 75% of the net offer allotted to qualified institutional buyers, and a full refund if that allocation fails.

SME platform. Chapter IX applies to small and medium enterprises listing on an SME exchange. Eligibility turns on post-issue paid-up capital (up to ₹10 crore, and up to ₹25 crore for issuers that may also use the route) and a minimum operating profit test, currently reported as ₹1 crore in two of the three preceding years. Draft documents on the SME route are examined at the exchange level. SEBI issued a consultation paper on 14 October 2026 proposing substantial changes to this framework, including a different profit test. These are proposals open for comment until 4 November 2026, not law. Any SME IPO plan should be reviewed against whatever is finally notified.

What the process involves. The issuer appoints a merchant banker as lead manager, files a draft offer document, and on the Main Board SEBI may issue observations. The draft is made public for comments for at least 21 days. Since March 2026 a draft abridged prospectus must also accompany the draft offer document. Promoters must hold at least 20% of the post-issue capital, and promoter and pre-issue shareholdings are subject to lock-in. Minimum promoters' contribution is generally locked in for 18 months (three years where the majority of proceeds, excluding any offer for sale, goes to capital expenditure), and other pre-issue capital for six months, with specified exceptions. Outstanding convertible securities generally have to be converted before the red herring prospectus, which matters for companies that have raised pre-IPO convertible rounds. Where the issue size excluding any offer for sale exceeds ₹100 crore, use of proceeds must be monitored by a credit rating agency.

An IPO takes the longest to prepare and has the heaviest disclosure burden. Eligibility is not approval: SEBI or the exchange may raise observations, and market conditions and investor demand cannot be assured.

3. Qualified Institutions Placement

A QIP is an issue of eligible securities by a listed issuer to qualified institutional buyers (QIBs) on a private placement basis under Chapter VI. QIBs include mutual funds, registered alternative investment funds, eligible foreign portfolio investors, public financial institutions, scheduled commercial banks, insurance companies and certain other institutions defined in Regulation 2(1)(ss). Eligible securities include equity shares and convertible securities other than warrants.

The issuer must have equity shares listed on a stock exchange with nationwide terminals for at least one year and must comply with minimum public shareholding norms. The placement needs a special resolution of shareholders and a placement document, which the lead manager files with the stock exchanges rather than SEBI. Key mechanics, as summarised in secondary sources and SEBI's investor charter material, include:

• a floor price based on the average of the weekly high and low closing prices over the two weeks before the relevant date, with a discount of up to 5% only if shareholders have approved it;

• at least 10% of the issue offered to mutual funds, with any unsubscribed portion open to other QIBs;

• at least two allottees for issues up to ₹250 crore and at least five above that, and no single allottee (with entities in the same group) taking more than 50%;

• no allotment to promoters or persons related to them; and

• shares sold only on a recognised stock exchange during the first year after allotment.

A QIP is generally the faster of the public-style routes for a listed company, because it avoids a prospectus and a SEBI review of an offer document. The trade-off is that the investor universe is institutional, so the company needs to be one institutions will take a view on, and pricing follows the market, not a negotiated valuation. SEBI's board considered a proposal in June 2025 to simplify the QIP placement document; its current legal status should be confirmed before relying on the existing Schedule VII disclosure requirements.

4. Preferential Issue

A preferential issue is an issue of specified securities by a listed issuer to any select person or group on a private placement basis under Chapter V. It is the usual tool for bringing in a strategic investor, converting promoter funding into equity, funding an acquisition through a share swap, or giving a financial investor a defined stake.

The issue requires a special resolution of shareholders, and no offer document is filed with SEBI. For frequently traded shares, the minimum price is the higher of the 90 trading-day and 10 trading-day volume-weighted average prices before the relevant date, or any stricter price set in the articles of association. Infrequently traded shares are priced on a valuation basis. A registered-valuer report is generally required where the issue results in a change of control or allots more than 5% of the post-issue fully diluted capital to one allottee or group. Allotment must be completed within 15 days of the shareholders' approval, subject to regulatory approvals. Shares allotted are locked in (18 months for promoter allottees and six months for others, from trading approval), and the allottee's existing shares are locked in from the relevant date for up to 90 trading days from trading approval.

The flexibility is real, but so is the scrutiny. Because the investor is chosen rather than found through a market process, the price formula, valuation and disclosure are what protect other shareholders. An allotment may also bring the Takeover Regulations into play.

5. Rights Issue and Other Alternatives

A rights issue offers new shares to existing shareholders as on a record date, in proportion to their holding. It is the route that best protects existing shareholders from dilution, because anyone who takes up the entitlement keeps their percentage. The 2025 amendments to the ICDR Regulations extended the rights issue chapter to issues of any size, removed the need to file a draft letter of offer with SEBI (it goes to the exchanges), and allowed renunciation of entitlements in favour of identified investors in specified circumstances. A SEBI circular of 11 March 2025 sets a 23 working-day timeline from board approval. The company needs shareholders who can and will subscribe, which limits the amount that can realistically be raised from a diffuse shareholder base.

Other options for listed companies include a follow-on public offer, an offer for sale by promoters, convertible instruments, and debt. Unlisted companies commonly use a private placement under the Companies Act before an IPO. Note that shares issued in a pre-IPO round at a price lower than the IPO price within the preceding year can be ineligible for computing minimum promoters' contribution unless the difference is paid to the issuer, so the timing and price of a pre-IPO round should be planned with the IPO in view.

6. Eligibility and Regulatory Conditions

Across routes, a few conditions recur. An issuer, its promoters or directors who are debarred from the capital market, or who are wilful defaulters, fraudulent borrowers or fugitive economic offenders, face restrictions on an IPO under Regulation 5 and comparable restrictions elsewhere in the framework. Listed companies must also keep up with the listing regulations, minimum public shareholding and the Companies Act private placement and share capital provisions, and exchanges give in-principle approval for QIP and preferential allotments.

These are summaries. The conditions, exceptions and cross-references in the regulations are detailed, and a transaction-specific legal review is needed.

7. Dilution, Cost and Execution Considerations

Dilution is arithmetic, and it is worth running before any route is chosen. The example below is hypothetical and uses round numbers.

A listed company has 10 crore shares, of which promoters hold 6 crore (60%). It raises ₹100 crore from new investors at ₹100 per share, issuing 1 crore new shares. Post-issue there are 11 crore shares; promoters hold 54.5%, the new investors 9.1% and other existing shareholders 36.4%. If the same ₹100 crore had to be raised at ₹80, the company would issue 1.25 crore shares, promoters would fall to 53.3% and the new investors would hold 11.1%. A lower price means more dilution for the same money, which is why price floors matter to existing shareholders.

Costs and effort differ in kind. An IPO involves the widest set of intermediaries, longest preparation and highest ongoing compliance. A QIP and a preferential issue are lighter on documents but still involve a merchant banker, legal counsel, valuers where required, and exchange approvals. A rights issue depends on shareholder response. Timelines vary by company and market conditions and should be mapped with advisers; this article does not offer a standard duration.

Whatever the route, the issue price, the valuation and the later market price are different things. An issue price set by formula or book building does not predict how shares trade after the transaction.

8. Matching the Fundraising Route to Business Needs

Three illustrative situations, all hypothetical:

• A profitable unlisted manufacturer wants growth capital and a public currency for acquisitions. The IPO is the relevant route, and the first question is whether it meets Regulation 6(1) or the SME criteria. A pre-IPO placement may be part of the plan.

• A listed company needs a large sum quickly for debt reduction and wants institutional investors. A QIP fits, provided the company is already attractive to institutions and has the necessary shareholder approval.

• A listed company wants one strategic partner to take a defined stake, or promoters wish to convert loans into equity. A preferential issue is the relevant tool, with attention to pricing, valuation, lock-in and open-offer implications.

Where the company's existing shareholders are the natural source of capital, a rights issue deserves a look before the others.

9. Questions Boards Should Consider

1. Are we listed, and if not, is an IPO the right first step? If so, do we meet Regulation 6 or the SME conditions today?

2. How much capital do we need, and by when? Is that amount realistic from institutions, a strategic investor or our existing shareholders?

3. What are the objects of the issue, and are they specific enough to disclose and monitor?

4. What dilution will result at plausible price points, and how does it change promoters' voting position?

5. Who is the investor we want, and does the route let us choose them?

6. What approvals, valuations and exchange or SEBI steps are involved, and who is responsible for each?

7. How will minority shareholders view the price and the allottee, and have we managed conflicts and related-party issues?

8. Do any pending regulatory proposals affect our timetable?

Common Mistakes to Avoid

• Treating a QIP or preferential issue as an alternative to an IPO for an unlisted company.

• Starting a pre-IPO round without checking pricing, convertible securities and lock-in consequences for the IPO.

• Anchoring on a target valuation without testing the price formula or the market.

• Underestimating disclosure and diligence effort, particularly for related-party and litigation matters.

• Relying on a regulatory change that is still a proposal.

Conclusion

The route follows from the company's status, the amount and type of investor sought, the timeline, and the willingness to accept dilution and disclosure. An unlisted company's capital-raising path runs through an IPO or private capital; a listed company can choose between a QIP, a preferential issue, a rights issue and other tools. Test the choice against the eligibility conditions and the dilution arithmetic before committing.

Next step: Evaluate potential capital-raising structures with appropriate professional advice. JDA Capital Services Limited can discuss your fundraising objectives and the routes that may be relevant. Call 079-6666 4040, email customercare@jdacapital.in, or use the Contact Us page.

Disclaimer: This article is for general educational purposes and is not legal, financial or investment advice. Regulatory requirements change, and applicability depends on a company's facts. Obtain transaction-specific professional advice.

• URL slug: /ipo-vs-qip-vs-preferential-issue-fundraising-route-india (final path to follow the JDA site structure)

• Meta description (about 150 characters): Compare IPO, QIP and preferential issue under SEBI ICDR: eligibility, investors, pricing, dilution and how boards can match a fundraising route to need.